Disease Management & Health Outcomes

, Volume 13, Issue 2, pp 129–135 | Cite as

Examining the Association Between Preventive Screenings and Subsequent Health Services Utilization by Patients with Type 2 Diabetes Mellitus

  • Fevzi Akinci
  • Joseph S. Coyne
  • Joni Minear
  • Kenn Daratha
  • Dan Simonson
Original Research Article
  • 13 Downloads

Abstract

Introduction

In recent years, health plans have turned to disease management programs as a means of reducing inpatient utilization while promoting preventive outpatient services provided for patients with type 2 diabetes mellitus.

Aim

The purpose of this study was to assess the association between four preventive diabetes screenings (retinal eye exams, glycosylated hemoglobin [HbA1c] testing, lipid testing, and albumin testing) in the base study period, and health services utilization patterns during a 24-month follow-up study period for 2641 patients with type 2 diabetes.

Methods

Claims data from Regence BlueShield of Idaho for the three periods of 2000 (base period), 2001, and 2002 (results period) have provided the basis for this empirical analysis. Based on our review of the relevant literature and results from disease management and health plan management programs, the central hypothesis of this study was that the four preventive diabetes screenings in the base study period would be associated with lower inpatient utilization and greater preventive outpatient utilization during a 24-month follow-up study period. Simple linear association analysis was used to measure the relationship between the utilization of preventive diabetes screenings and subsequent utilization of emergency room, inpatient, and preventive outpatient services.

Results

The study results show that for patients who comply with recommended lipid screening services, health plans can expect to see a significant reduction in the number of inpatient admissions over the subsequent 2 years, while marginal inpatient reductions might be expected following HbA1c testing. Furthermore, for patients who comply with recommended screenings of either retinal eye exams or albumin testing, health plans can expect to see these patients utilizing preventive outpatient services more frequently in the subsequent 2 years.

Conclusions

Pursuing a state- or federal-supported screening program for patients with type 2 diabetes could reduce frequent utilization of inpatient services. Furthermore, in support of the goal of disease management programs to reduce inpatient utilization and increase preventive outpatient service utilization among the increasing proportion of members with type 2 diabetes, health plans are encouraged to provide education about and monitor their patients’ compliance with recommended screenings in the future. Further studies should examine the role of lipid testing in reducing the risk of microvascular diseases. Future research should also pursue an understanding of how a reduction in inpatient utilization is associated with an increased emphasis on lipid screening.

Keywords

Health Plan Disease Management Program Inpatient Admission Preventive Screening Case Management Program 

Notes

Acknowledgments

The authors gratefully acknowledge the careful review, insightful comments, and suggestions of both outside and editorial reviewers on an earlier version of this manuscript.

The authors also wish to acknowledge the bibliographical and editorial contributions of Ms Jill Royston, WSU Health Policy and Administration Department Program Assistant, and statistical and graphical analysis assistance from Mr Sher G. Singh.

No sources of funding were used to assist in the preparation of this study. The authors have no conflicts of interest that are directly relevant to the content of this study.

References

  1. 1.
    Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States 2003, C.f.D.C.a. Prevention, Editor. Atlanta (GA): US Department of Health and Human Services, 2003Google Scholar
  2. 2.
    Selby JV, Ray GT, Zhang D, et al. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997; 20: 1396–402PubMedCrossRefGoogle Scholar
  3. 3.
    Krop J, Powe NR, Weller WE, et al. Patterns of expenditures and use of service among older adults with diabetes: implications for the transition to capitated managed care. Diabetes Care 1998; 21: 747–52PubMedCrossRefGoogle Scholar
  4. 4.
    Donnon P, Leese GP, Morris AD. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. Diabetes Care 2000; 23: 1774–9CrossRefGoogle Scholar
  5. 5.
    Killilea T. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care. Am J Manag Care 2002; 8(16 Suppl.): S441–9PubMedGoogle Scholar
  6. 6.
    Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26(3): 917–32PubMedCrossRefGoogle Scholar
  7. 7.
    Jiang H, Stryer D, Friedman B, et al. Multiple hospitalizations for patients with diabetes. Diabetes Care 2003; 26: 1421–6PubMedCrossRefGoogle Scholar
  8. 8.
    Niefeld M, Braunstein JB, Wu AW, et al. Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. Diabetes Care 2003; 26: 1344–9PubMedCrossRefGoogle Scholar
  9. 9.
    Egede L, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25: 464–70PubMedCrossRefGoogle Scholar
  10. 10.
    Nichols G, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care 2002; 25: 482–6PubMedCrossRefGoogle Scholar
  11. 11.
    Ashton C, Septimus J, Petersen NJ, et al. Healthcare use by veterans treated for diabetes mellitus in the Veterans Affairs Medical Care System. Am J Manag Care 2003; 9: 145–50PubMedGoogle Scholar
  12. 12.
    Simpson S, Corabian P, Jacobs P, et al. The cost of major comorbidity in people with diabetes mellitus. CMAJ 2003; 168: 1661–7PubMedGoogle Scholar
  13. 13.
    Brown J, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999; 159: 1873–80PubMedCrossRefGoogle Scholar
  14. 14.
    Ramsey S, Newton K, Blough D, et al. Patient-level estimates of the cost of complications in diabetes in a managed-care population. Pharmacoeconomics 1999; 16: 285–95PubMedCrossRefGoogle Scholar
  15. 15.
    CDC Diabetes in Managed Care Work Group. Diabetes mellitus in managed care: complications and resource utilization. Am J Manag Care 2001; 7: 501–8Google Scholar
  16. 16.
    Selby J, Karter AJ, Ackerson LM, et al. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care 2001; 24: 1547–55PubMedCrossRefGoogle Scholar
  17. 17.
    Caro J, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the US. Diabetes Care 2002; 25: 476–81PubMedCrossRefGoogle Scholar
  18. 18.
    Bindman A, Grumbach K, Osmond D, et al. Preventable hospitalizations and access to health care. JAMA 1995; 274: 305–11PubMedCrossRefGoogle Scholar
  19. 19.
    Blustein J, Hanson K, Shea S. Preventable hospitalizations and socioeconomic status. Health Aff 1998; 17: 177–89CrossRefGoogle Scholar
  20. 20.
    Millman ME, editor. Access to health care in America. Washington, DC: Institute of Medicine, 1993Google Scholar
  21. 21.
    Klarenbach S, Jacobs P. International comparison of health resource utilization in subjects with diabetes: an analysis of Canadian and American national health surveys. Diabetes Care 2003; 26: 1116–22PubMedCrossRefGoogle Scholar
  22. 22.
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14): 977–86CrossRefGoogle Scholar
  23. 23.
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352(9131): 837–53CrossRefGoogle Scholar
  24. 24.
    Akinci F, Healey B, Coyne J. Improving the health status of US working adults with type 2 diabetes. Dis Manag Health Outcomes 2003; 11(8): 489–98CrossRefGoogle Scholar
  25. 25.
    Akinci F, Coyne J, Healey B. Interventions for the diabetes disease state: a comparative financial analysis. Chicago (IL): Midwest Business Administration Association, 2003Google Scholar
  26. 26.
    Akinci F, Coyne J, Healey B, et al. National performance measures for diabetes care: implications for health care providers diabetes. Dis Manag Health Outcomes 2004; 12(5): 285–98CrossRefGoogle Scholar
  27. 27.
    Lafata J, Martin S, Morlock R, et al. Provider type and the receipt of general and diabetes-related preventive health services among patients with diabetes. Med Care 2001; 39: 491–9PubMedCrossRefGoogle Scholar
  28. 28.
    Roubideaux Y, Buchwald D, Beals J, et al. Measuring the quality of diabetes care for older American Indians and Alaska Natives. Am J Public Health 2004; 94: 60–5PubMedCrossRefGoogle Scholar
  29. 29.
    American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2001; 24: S33–43CrossRefGoogle Scholar
  30. 30.
    Wagner E, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996; 74(4): 511–44PubMedCrossRefGoogle Scholar
  31. 31.
    Norris S, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes: a systematic review. Am J Prev Med 2002; 22(4 Suppl.): 15–38PubMedCrossRefGoogle Scholar
  32. 32.
    McGlynn E, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348(26): 2635–45PubMedCrossRefGoogle Scholar
  33. 33.
    Clark Jr C, Snyder JW, Meek RL, et al. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 2001; 24(6): 1079–86PubMedCrossRefGoogle Scholar
  34. 34.
    Saaddine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002; 136(8): 565–74PubMedGoogle Scholar
  35. 35.
    TRIAD Study Group. The Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2002; 25(2): 386–9CrossRefGoogle Scholar
  36. 36.
    Koro C, Bowlin SJ, Bourgeois N, et al. Glycemic control from 1998 to 2000 among US adults diagnosed with type 2 diabetes. Diabetes Care 2004; 27: 17–20PubMedCrossRefGoogle Scholar
  37. 37.
    Jencks SF, Cuerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: a profile at state and national levels. JAMA 2000; 284(13): 1670–6PubMedCrossRefGoogle Scholar
  38. 38.
    Jencks S, Huff ED, Cuerdon T. Change in the quality of care delivered to Medicare beneficiaries 1998–1999. JAMA 2003; 289(3): 305–12PubMedCrossRefGoogle Scholar
  39. 39.
    Welch W, Bersten C, Cutler C, et al. Disease management practices of health plans. Am J Manag Care 2002; 8(4): 353–61PubMedGoogle Scholar
  40. 40.
    Short A, Mays G, Mittler J. Disease management: a leap of faith to lower-cost, higher-quality health care. Issue Brief Cent Health Syst Change 2003; 69: 1–4Google Scholar
  41. 41.
    Schauffler H, Chapman SA. Health promotion and managed care: surveys of California’s health plans and population. Am J Prev Med 1998; 14(3): 161–7PubMedCrossRefGoogle Scholar
  42. 42.
    Dove H, Duncan I, Robb A. A prediction model for targeting low-cost, high-risk members of managed care organizations. Am J Manag Care 2003; 9(5): 381–9PubMedGoogle Scholar
  43. 43.
    Rubin RJ, Dietrich KA, Hawk AD. Clinical and economic impact of implementing a comprehensive diabetes management program in managed care. J Clin Endocrinol Metab 1998; 83(8): 2635–42PubMedCrossRefGoogle Scholar
  44. 44.
    Domurat E. Diabetes managed care and clinical outcomes: the Harbor City, California Kaiser Permanente diabetes care system. Am J Manag Care 1999; 5(10): 1299–307PubMedGoogle Scholar
  45. 45.
    Steffens B. Cost-effective management of type 2 diabetes: providing quality care in a cost-constrained environment. Am J Manag Care 2000; 6(13 Suppl.): S697–703PubMedGoogle Scholar
  46. 46.
    Sadur CN, Moline N, Costa M, et al. Diabetes management in a health maintenance organization: efficacy of care management using cluster visits. Diabetes Care 1999; 22(12): 2011–7PubMedCrossRefGoogle Scholar
  47. 47.
    Sidorov J, Shull R, Tomcavage J, et al. Does diabetes management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria. Diabetes Care 2002; 25: 684–9PubMedCrossRefGoogle Scholar
  48. 48.
    Testa MA, Dimonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 1998; 280(17): 1490–6PubMedCrossRefGoogle Scholar
  49. 49.
    Menzin J, Langley-Hawthorne C, Friedman M, et al. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2001; 24(1): 51–5PubMedCrossRefGoogle Scholar
  50. 50.
    Berg GD, Wadhwa S. Diabetes disease management in a community-based setting. Manag Care 2002; 11(6): 42, 45–50PubMedGoogle Scholar
  51. 51.
    NCQA. The state of health care quality 2002. Industry trends and analysis. Washington, DC: NCQA, 2002Google Scholar
  52. 52.
    Mensing C, Boucher J, Cypress M, et al. National standards for diabetes selfmanagement education. Diabetes Care 2002; 25 Suppl. 1: S140–7CrossRefGoogle Scholar
  53. 53.
    Gilmer TP, O’Connor PJ. Cost effectiveness of diabetes mellitus management programs. Dis Manage Health Outcomes 2003; 11(7): 439–53CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Fevzi Akinci
    • 1
    • 2
  • Joseph S. Coyne
    • 1
    • 2
    • 3
  • Joni Minear
    • 2
    • 4
  • Kenn Daratha
    • 1
    • 2
  • Dan Simonson
    • 1
    • 2
  1. 1.Department of Health Policy and AdministrationWashington State UniversitySpokaneUSA
  2. 2.Center for International Health Services Research and PolicyWashington State UniversitySpokaneUSA
  3. 3.Boconni UniversityMilanItaly
  4. 4.Regence BlueShield of IdahoLewistonUSA

Personalised recommendations